We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Fisher & Paykel Healthcare

Fisher & Paykel Healthcare offers a broad range of products and systems for use in respiratory and acute care and in ... read more Featured Products: More products

Download Mobile App





Fisher & Paykel Demonstrates Humidified Nasal High Flow System for Delivering Respiratory Support at MEDICA 2021

By HospiMedica International staff writers
Posted on 18 Nov 2021
Print article
Image: Airvo 2 Nasal High Flow System (Photo courtesy of Fisher & Paykel Healthcare)
Image: Airvo 2 Nasal High Flow System (Photo courtesy of Fisher & Paykel Healthcare)

Fisher & Paykel Healthcare (F&P; Auckland, New Zealand) demonstrated its Airvo 2 nasal high flow (NHF) system that is designed to deliver proven respiratory support at MEDICA 2021.

The F&P Respiratory Care Continuum illustrates the breadth of respiratory therapies patients may require when in need of respiratory assistance. NHF is recognized by the WHO for treatment of patients with COVID-19. NHF has been used as respiratory support throughout the pandemic and its use on COVID-19 patients has been observed to keep patients off mechanical ventilation and help them stay off, lower the rate of mortality, and reduce length of stay.

The Airvo 2 is an integrated solution for delivering Optiflow high flow therapy. F&P’s leading humidification technology allows the Airvo 2 to comfortably provide high flows of humidified air (with supplemental oxygen if required) to spontaneously breathing patients, through the unique series of Optiflow interfaces. It features three temperature settings, including 37°C (body temperature pressure saturated for a normothermic patient) i.e. optimal humidity. An integrated flow generator delivers a wide flow range 10 - 60 L/min for adult patients and 2 - 25 L/min for pediatric patients, taking patients from the most acute environments (ICU and ED) to the home.

It also features F&P’s Evaqua technology which reduces the formation of mobile condensate. Oxygen can be added from a wall supply or cylinder. Its in-built ultrasonic oxygen analyzer requires no calibration, service or replacement. No separate temperature probes or heater-wire adapters are required. The Airvo 2, with its wide range of accessories, provides versatility, mobility and convenience. A compact system with a built-in flow generator means there’s no need for a noisy, heavy air compressor in order to use the Airvo 2 for transport. A suitable UPS can be added, and the Airvo 2 is ready to go.

Related Links:
Fisher & Paykel Healthcare 


Print article
Clear Image Devices
Radcal

Channels

Business

view channel
Image: 44th World Hospital Congress (WHC) Ends on Upbeat Note as Hospital Leaders Look to Build Resilience (Photo courtesy of IHF)

44th World Hospital Congress (WHC) Ends on Upbeat Note as Hospital Leaders Look to Build Resilience

The 44th World Hospital Congress (WHC) organized by The International Hospital Federation (IHF; Geneva, Switzerland) on 8-11 November 2021 in Barcelona, Spain came to an upbeat close. During the event,... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.